Fas/FasL and Complement Activation are Associated with Chronic Active Epstein-Barr Virus Hepatitis

Jing Lin1, Miao-Fang Su1, Jiao-Long Zheng1

  • 1Department of Hepatobiliary Medicine, Fuzong Clinical Medical College of Fujian Medical University, 900TH Hospital of the Joint Logistic Support Force, PLA, Fuzhou, Fujian, China.

Insights

Chronic active Epstein-Barr virus hepatitis (CAEBVH) is a severe liver disease. Our study reveals immune cell dysfunction and complement system activation are key pathogenic mechanisms in CAEBVH.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Chronic active Epstein-Barr virus hepatitis (CAEBVH) is a rare, lethal condition causing liver inflammation and enlargement.
  • Understanding its clinicopathological features and disease mechanisms is crucial for patient outcomes.

Purpose of the Study:

  • To investigate the clinicopathological characteristics of CAEBVH.
  • To elucidate the pathogenic mechanisms underlying CAEBVH.

Main Methods:

  • Analysis of clinicopathological data from ten CAEBVH patients.
  • Flow cytometry for immune cell phenotyping.
  • Whole exome sequencing and immunohistochemistry for genetic and molecular mechanisms.

Main Results:

  • Patients presented with fever, hepatosplenomegaly, abnormal liver function, and CD8+ T cell lymphopenia.
  • Liver biopsies showed lymphocytic infiltration and Epstein-Barr virus-encoded small RNA (EBER) positivity.
  • Enhanced expression of cytotoxic T lymphocyte markers, apoptosis-related proteins (Fas/FasL, Caspase-8), and complement components (C1q, C3d) was observed.

Conclusions:

  • CAEBVH is characterized by fever, hepatosplenomegaly, and lymphadenopathy.
  • Histopathology reveals lymphocytic infiltration and EBER positivity.
  • Fas/FasL pathway and complement activation are implicated in CAEBVH pathogenesis.
Abstract